3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
2
Advanced Malignancies
2
Urothelial Cancer
1
Thyroid Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
KRAS p.G12C Mutant Advanced Solid Tumors
1
Hematologic Neoplasms
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Gemcitabine
57
130-nm albumin-bound paclitaxel
35
Specimen Handling
26
Magnetic Resonance Spectroscopy
21
Albumin-Bound Paclitaxel
21
Fluorouracil
20
Leucovorin
19
Irinotecan
19
Oxaliplatin
17
Biopsy
17
Taxes
16
pembrolizumab
13
Cyclophosphamide
11
Cisplatin
11
fludarabine
10
Cetuximab
9
Capecitabine
8
Nivolumab
7
Carboplatin
7
irinotecan sucrosofate
6
durvalumab
6
dehydroftorafur
6
Radiosurgery
6
Pemetrexed
6
olaparib
5
Ipilimumab
5
Erlotinib Hydrochloride
5
trastuzumab deruxtecan
4
aldesleukin
4
Radiotherapy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
Midazolam
×
90 days
×
Clear all
No trials found.